Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Soluble antigens and cytokines are a diverse group of extracellular proteins that facilitate intercellular communication and immune system regulation. Cytokines, including interleukins, chemokines, and interferons, serve as signaling molecules that bind to specific cell-surface receptors to initiate biological responses such as inflammation, cell proliferation, and immune cell activation (StatPearls, 2023). Soluble antigens are circulating molecules, often derived from pathogens or tumor cells, that can be recognized by the immune system or targeted by therapeutic antibodies (PubMed, 1988). In pathological states like rheumatoid arthritis or cytokine storm syndromes, the overproduction of these factors leads to tissue damage and systemic inflammation. Many blockbuster drugs, such as TNF inhibitors and IL-1 beta antagonists, work by binding and neutralizing these soluble mediators to prevent them from activating their cognate receptors (Nature Reviews Drug Discovery, 2018). Because this term refers to a broad functional class rather than a single molecular entity, it is classified as a category of targets rather than a specific therapeutic target. Targeting these molecules requires high specificity to avoid broad immunosuppression while effectively dampening the specific pathway driving the disease. Monitoring levels of these soluble factors often serves as a diagnostic or prognostic tool in clinical settings.
Neutralization of soluble signaling molecules (cytokines or ligands) to prevent their interaction with cell-surface receptors, thereby inhibiting downstream signaling pathways.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Soluble antigens and cytokines.